Literature DB >> 17669216

Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses.

T M Robinson1, M K Sidhu, G N Pavlakis, B K Felber, P Silvera, M G Lewis, J Eldridge, D B Weiner, J D Boyer.   

Abstract

BACKGROUND: The cell mediated immune profiles following immunization with a recombinant DNA vaccine was assessed in the simian-human immunodeficiency virus (SHIV) and Macaque model. Earlier work demonstrated increased numbers of antigen specific CD8 and CD4 effector cells able to secrete IFN-gamma.
METHOD: The vaccine strategy included co-immunization of a DNA based vaccine alone or in combination with a macaque IL-12 expressing plasmid (pmacIL12). Antigen activated lymphocytes were studied for activation of a set of immunological molecules.
RESULTS: The current study demonstrates lymphocytes isolated and activated from the group that was immunized with DNA and pmacIL12 had a higher level of IFN-gamma producing cells. We also observed a different immunological profile when comparing the cells isolated from macaques immunized with DNA as compared to those animals that also received pmacIL12.
CONCLUSION: The observed immune profiles are reflective of the co-delivery of pmacIL12 and demonstrates that IL-12 can increase the magnitude and polyfunctionality of the cellular immune response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669216     DOI: 10.1111/j.1600-0684.2007.00245.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  13 in total

1.  Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.

Authors:  Viraj Kulkarni; Margherita Rosati; Jenifer Bear; Guy R Pilkington; Rashmi Jalah; Cristina Bergamaschi; Ashish K Singh; Candido Alicea; Bhabadeb Chowdhury; Gen-Mu Zhang; Eun-Young Kim; Steven M Wolinsky; Wensheng Huang; Yongjun Guan; Celia LaBranche; David C Montefiori; Kate E Broderick; Niranjan Y Sardesai; Antonio Valentin; Barbara K Felber; George N Pavlakis
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

2.  IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques.

Authors:  Rashmi Jalah; Vainav Patel; Viraj Kulkarni; Margherita Rosati; Candido Alicea; Brunda Ganneru; Agneta von Gegerfelt; Wensheng Huang; Yongjun Guan; Kate E Broderick; Niranjan Y Sardesai; Celia LaBranche; David C Montefiori; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.

Authors:  Timothy R Fouts; Kenneth Bagley; Ilia J Prado; Kathryn L Bobb; Jennifer A Schwartz; Rong Xu; Robert J Zagursky; Michael A Egan; John H Eldridge; Celia C LaBranche; David C Montefiori; Hélène Le Buanec; Daniel Zagury; Ranajit Pal; George N Pavlakis; Barbara K Felber; Genoveffa Franchini; Shari Gordon; Monica Vaccari; George K Lewis; Anthony L DeVico; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-13       Impact factor: 11.205

4.  Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.

Authors:  Viraj Kulkarni; Margherita Rosati; Antonio Valentin; Rashmi Jalah; Candido Alicea; Lei Yu; Yongjun Guan; Xiaoying Shen; Georgia D Tomaras; Celia LaBranche; David C Montefiori; Carmela Irene; Rajasekhar Prattipati; Abraham Pinter; Sean M Sullivan; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2013-07-02       Impact factor: 3.452

5.  The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.

Authors:  Jeffrey M Jacobson; Lu Zheng; Cara C Wilson; Pablo Tebas; Roy M Matining; Michael A Egan; John Eldridge; Alan L Landay; David B Clifford; Anne F Luetkemeyer; Jennifer Tiu; Ana L Martinez; Jennifer Janik; Teresa A Spitz; John Hural; Juliana McElrath; Nicole Frahm
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

6.  Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.

Authors:  Thorsten Demberg; Jean D Boyer; Nina Malkevich; L Jean Patterson; David Venzon; Ebonita L Summers; Irene Kalisz; V S Kalyanaraman; Eun Mi Lee; David B Weiner; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

7.  Variability of bio-clinical parameters in Chinese-origin Rhesus macaques infected with simian immunodeficiency virus: a nonhuman primate AIDS model.

Authors:  Song Chen; Chunhui Lai; Xiaoxiang Wu; Yaozheng Lu; Daishu Han; Weizhong Guo; Linchun Fu; Jean-Marie Andrieu; Wei Lu
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

8.  Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques.

Authors:  Antonio Valentin; Jinyao Li; Margherita Rosati; Viraj Kulkarni; Vainav Patel; Rashmi Jalah; Candido Alicea; Steven Reed; Niranjan Sardesai; Ira Berkower; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 9.  HIV DNA Vaccine: Stepwise Improvements Make a Difference.

Authors:  Barbara K Felber; Antonio Valentin; Margherita Rosati; Cristina Bergamaschi; George N Pavlakis
Journal:  Vaccines (Basel)       Date:  2014-05-14

10.  DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques.

Authors:  Rashmi Jalah; Viraj Kulkarni; Vainav Patel; Margherita Rosati; Candido Alicea; Jenifer Bear; Lei Yu; Yongjun Guan; Xiaoying Shen; Georgia D Tomaras; Celia LaBranche; David C Montefiori; Rajasekhar Prattipati; Abraham Pinter; Julian Bess; Jeffrey D Lifson; Steven G Reed; Niranjan Y Sardesai; David J Venzon; Antonio Valentin; George N Pavlakis; Barbara K Felber
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.